Dominic Martin Etienne Page
Director/Board Member at Abcam (US) Ltd.
Dominic Martin Etienne Page active positions
| Companies | Position | Start | End |
|---|---|---|---|
Abcam (US) Ltd.
 Abcam (US) Ltd. Financial ConglomeratesFinance Part of Abcam Plc, Abcam (US) Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2012. | Director/Board Member | 2019-03-25 | - |
Firefly BioWorks, Inc.
 Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
| Treasurer | - | - |
Career history of Dominic Martin Etienne Page
Statistics
International
| United Kingdom | 2 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Treasurer | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Abcam (US) Ltd.
Abcam (US) Ltd. Financial ConglomeratesFinance Part of Abcam Plc, Abcam (US) Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2012. | Finance |
Firefly BioWorks, Inc.
Firefly BioWorks, Inc. Medical SpecialtiesHealth Technology Firefly BioWorks, Inc. develops an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. It offers Multiplex Cellular miRNA and Multiplex Circulating miRNA Assays that use Firefly particle technology to enable simultaneous analysis of 68 miRNAs per well; and vacuum manifold for 96 well filter plates. The company was founded by Davide M. Marini and Daniel C. Pregibon in 2009 and is headquartered in Cambridge, MA. | Health Technology |
